Breaking News

Gates Foundation Establishes $125M COVID-19 Fund

Aims to help identify and advance possible COVID-19 treatments and help prepare for the manufacture of millions of doses

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Bill & Melinda Gates Foundation has established a $125 million fund, the COVID-19 Therapeutics Accelerator, in an effort to accelerate the development of treatments and to curb the spread of the coronavirus. Through a joint-venture with Wellcome Trust and Mastercard, the Bill & Melinda Gates Foundation is supporting financial efforts to combat coronavirus. The funds aim to help identify and advance possible COVID-19 treatments and help prepare for the manufacture of millions of doses...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters